Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence F Eichenfield

Showing results (211-220 of 376) with videos related to

Pageof 38
Sort By:
Pediatric Dermatology|January 19, 2019
The microbiome in preadolescent acne: Assessment and prospective analysis of the influence of benzoyl peroxideJusleen Ahluwalia, Jenna Borok, Ellen S Haddock, et al.
American Journal of Clinical Dermatology|February 18, 2021
Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum ContagiosumLawrence F Eichenfield, Elaine Siegfried, Pearl Kwong, et al.
JAMA Dermatology|February 27, 2020
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical TrialEmma Guttman-Yassky, Andrew Blauvelt, Lawrence F Eichenfield, et al.
JAAD International|August 19, 2021
Therapeutic education in atopic dermatitis: A position paper from the International Eczema CouncilLawrence F Eichenfield, Ayan Kusari, Allison M Han, et al.
Cutis|December 19, 2015
Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 1: overview, clinical characteristics, and laboratory evaluationJames Q Del Rosso, Julie C Harper, Emmy M Graber, et al.
Seminars in Cutaneous Medicine and Surgery|September 13, 2017
Atopic dermatitis: skin care and topical therapiesDavid M Fleischer, Jeremy Udkoff, Jenna Borok, et al.
Pediatric Dermatology|April 20, 2025
Patient-Reported Impact of Atopic Dermatitis on Pediatric and Adolescent Patients With Moderate-To-Severe Disease: Results of a Real-World, Cross-Sectional SurveyLawrence F Eichenfield, Vivian Y Shi, JiaDe Yu, et al.
American Journal of Clinical Dermatology|April 17, 2026
Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis TreatmentLawrence F Eichenfield, Peter A Lio, Alan D Irvine, et al.
JAMA Dermatology|September 23, 2020
Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical TrialsLawrence F Eichenfield, Wendy McFalda, Bradford Brabec, et al.
Journal of Drugs in Dermatology : JDD|June 4, 2024
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne in Adult and Pediatric ParticipantsHilary Baldwin, Linda Stein Gold, Julie C Harper, et al.
Pageof 38

Showing results (211-220 of 376) with videos related to

Sort By:
Pageof 38
Pediatric Dermatology|January 19, 2019
The microbiome in preadolescent acne: Assessment and prospective analysis of the influence of benzoyl peroxideJusleen Ahluwalia, Jenna Borok, Ellen S Haddock, et al.
American Journal of Clinical Dermatology|February 18, 2021
Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum ContagiosumLawrence F Eichenfield, Elaine Siegfried, Pearl Kwong, et al.
JAMA Dermatology|February 27, 2020
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical TrialEmma Guttman-Yassky, Andrew Blauvelt, Lawrence F Eichenfield, et al.
JAAD International|August 19, 2021
Therapeutic education in atopic dermatitis: A position paper from the International Eczema CouncilLawrence F Eichenfield, Ayan Kusari, Allison M Han, et al.
Cutis|December 19, 2015
Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 1: overview, clinical characteristics, and laboratory evaluationJames Q Del Rosso, Julie C Harper, Emmy M Graber, et al.
Seminars in Cutaneous Medicine and Surgery|September 13, 2017
Atopic dermatitis: skin care and topical therapiesDavid M Fleischer, Jeremy Udkoff, Jenna Borok, et al.
Pediatric Dermatology|April 20, 2025
Patient-Reported Impact of Atopic Dermatitis on Pediatric and Adolescent Patients With Moderate-To-Severe Disease: Results of a Real-World, Cross-Sectional SurveyLawrence F Eichenfield, Vivian Y Shi, JiaDe Yu, et al.
American Journal of Clinical Dermatology|April 17, 2026
Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis TreatmentLawrence F Eichenfield, Peter A Lio, Alan D Irvine, et al.
JAMA Dermatology|September 23, 2020
Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical TrialsLawrence F Eichenfield, Wendy McFalda, Bradford Brabec, et al.
Journal of Drugs in Dermatology : JDD|June 4, 2024
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne in Adult and Pediatric ParticipantsHilary Baldwin, Linda Stein Gold, Julie C Harper, et al.
Pageof 38